Real-world medication use patterns in stable COPD patients from Romania

F. Mihaltan (Bucharest, Romania), P. Postolache (Iasi, Romania), O. Arghir (Constanta, Romania), O. Fira-Mladinescu (Timisoara, Romania), A. Silviu (Bucharest, Romania)

Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Session: COPD treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2492
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Mihaltan (Bucharest, Romania), P. Postolache (Iasi, Romania), O. Arghir (Constanta, Romania), O. Fira-Mladinescu (Timisoara, Romania), A. Silviu (Bucharest, Romania). Real-world medication use patterns in stable COPD patients from Romania. 2492

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Prescription rates for various classes of COPD & asthma medication in Turkey
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Clinical and inhaled drug profile of COPD patients with indication for beta-blockers who are on beta-blockers
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


Prevalence of asthma characteristics in COPD patients in a Dutch well-established asthma/COPD service for primary care
Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care
Year: 2019




De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012


Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain
Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs
Year: 2018


Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen
Source: Eur Respir J 2003; 22: Suppl. 45, 375s
Year: 2003

Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Self-reported medication use in Italian adults: temporal changes and polypharmacy
Source: Eur Respir J 2006; 28: Suppl. 50, 687s
Year: 2006

Use of maintenance medications in patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey
Source: Eur Respir J 2002; 20: Suppl. 38, 47s
Year: 2002